| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 1.96e-35 | 431 | 62 | 31 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 MRGPRX3 OR10H4 OR5AK3P MRGPRX4 OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 OR2W6P | 1.99e-34 | 884 | 62 | 37 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 IL1RAPL2 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 MRGPRX3 OR10H4 TRPV4 OR5AK3P MRGPRX4 OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 OR2W6P | 1.98e-30 | 1353 | 62 | 39 | GO:0004888 |
| GeneOntologyMolecularFunction | odorant binding | 1.95e-10 | 127 | 62 | 9 | GO:0005549 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 5.15e-06 | 37 | 62 | 4 | GO:0042923 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.01e-05 | 14 | 62 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.25e-05 | 46 | 62 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 ATP1A4 | 1.27e-05 | 465 | 62 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.20e-05 | 53 | 62 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.02e-05 | 129 | 62 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 9.43e-05 | 5 | 62 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.06e-04 | 151 | 62 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 ATP1A4 | 1.29e-04 | 627 | 62 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 TMC5 ATP1A4 | 1.52e-04 | 793 | 62 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.89e-04 | 171 | 62 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 ATP1A4 | 1.98e-04 | 664 | 62 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 4.20e-04 | 10 | 62 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 4.20e-04 | 10 | 62 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 5.12e-04 | 11 | 62 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 ATP1A4 | 5.22e-04 | 758 | 62 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 5.35e-04 | 459 | 62 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.85e-04 | 334 | 62 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 7.78e-04 | 133 | 62 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 9.42e-04 | 140 | 62 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | channel activity | 1.18e-03 | 525 | 62 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.19e-03 | 526 | 62 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.28e-03 | 152 | 62 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.41e-03 | 18 | 62 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.30e-03 | 23 | 62 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.47e-03 | 182 | 62 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.57e-03 | 184 | 62 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.17e-03 | 27 | 62 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 TMC5 ATP1A4 | 3.24e-03 | 1180 | 62 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 4.16e-03 | 31 | 62 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.22e-03 | 343 | 62 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 5.58e-03 | 36 | 62 | 2 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 5.58e-03 | 36 | 62 | 2 | GO:0015662 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 SLC5A7 TRPV4 ATP1A1 TMC5 ATP1A4 | 6.03e-03 | 1289 | 62 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 7.54e-03 | 42 | 62 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | actinin binding | 7.89e-03 | 43 | 62 | 2 | GO:0042805 | |
| GeneOntologyMolecularFunction | ADP binding | 9.76e-03 | 48 | 62 | 2 | GO:0043531 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.42e-02 | 301 | 62 | 4 | GO:0022853 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 7.86e-36 | 432 | 62 | 31 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 7.94e-35 | 465 | 62 | 31 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 2.97e-34 | 485 | 62 | 31 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR10A3 OR2W3 OR51T1 CACNA1F OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 2.30e-33 | 582 | 62 | 32 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 3.32e-33 | 524 | 62 | 31 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 1.26e-32 | 547 | 62 | 31 | GO:0007606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR10A3 OR2W3 OR51T1 CACNA1D OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 MRGPRX3 OR10H4 OR5AK3P MRGPRX4 OR2J1 OR6K3 OR4C12 OR10J4 VPS54 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 OR2W6P | 1.87e-30 | 1395 | 62 | 39 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR10A3 OR2W3 OR51T1 CACNA1F OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 2.20e-30 | 722 | 62 | 32 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR10A3 OR2W3 OR51T1 CACNA1D CACNA1F OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 2.49e-26 | 1072 | 62 | 33 | GO:0007600 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 2.26e-07 | 142 | 62 | 7 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 2.26e-07 | 142 | 62 | 7 | GO:0098659 | |
| GeneOntologyBiologicalProcess | response to chloroquine | 2.58e-07 | 5 | 62 | 3 | GO:1902349 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 5.71e-06 | 230 | 62 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.30e-05 | 48 | 62 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.30e-05 | 48 | 62 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 HMGCR VPS54 ATP1A1 ATP1A4 | 4.80e-05 | 866 | 62 | 11 | GO:0055082 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1C CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 VPS54 ATP1A1 ATP1A4 | 8.28e-05 | 611 | 62 | 9 | GO:0030003 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 8.84e-05 | 5 | 62 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1C CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 VPS54 ATP1A1 ATP1A4 | 9.48e-05 | 622 | 62 | 9 | GO:0006873 |
| GeneOntologyBiologicalProcess | chemosensory behavior | 1.09e-04 | 31 | 62 | 3 | GO:0007635 | |
| GeneOntologyBiologicalProcess | export from cell | CACNA1C CACNA1D TPCN2 NPY5R P2RY1 MRGPRX1 MRGPRX3 TRPV4 MRGPRX4 HMGCR ATP1A1 ATP1A4 | 1.41e-04 | 1153 | 62 | 12 | GO:0140352 |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 HMGCR VPS54 ATP1A1 ATP1A4 | 1.46e-04 | 981 | 62 | 11 | GO:0019725 |
| GeneOntologyBiologicalProcess | calcium ion import | 2.16e-04 | 98 | 62 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1C CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 VPS54 ATP1A1 ATP1A4 | 2.43e-04 | 705 | 62 | 9 | GO:0055080 |
| GeneOntologyBiologicalProcess | osmosensory signaling pathway | 2.46e-04 | 8 | 62 | 2 | GO:0007231 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1C CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 VPS54 ATP1A1 ATP1A4 | 2.75e-04 | 717 | 62 | 9 | GO:0050801 |
| GeneOntologyBiologicalProcess | vesicle-mediated cholesterol transport | 3.16e-04 | 9 | 62 | 2 | GO:0090119 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 TRPV4 CD151 ATP1A1 ATP1A4 MEGF10 CXCR1 | 3.19e-04 | 1074 | 62 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 4.80e-04 | 11 | 62 | 2 | GO:0010248 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 4.89e-04 | 217 | 62 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.89e-04 | 217 | 62 | 5 | GO:0097553 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 5.26e-04 | 622 | 62 | 8 | GO:0098771 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 5.30e-04 | 124 | 62 | 4 | GO:0007218 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokinesis | 6.07e-04 | 55 | 62 | 3 | GO:0032467 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 7.21e-04 | 359 | 62 | 6 | GO:0006874 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 7.46e-04 | 59 | 62 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | acute-phase response | 7.46e-04 | 59 | 62 | 3 | GO:0006953 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle contraction | 7.46e-04 | 59 | 62 | 3 | GO:0045933 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 8.62e-04 | 62 | 62 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | acute inflammatory response | 9.05e-04 | 143 | 62 | 4 | GO:0002526 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 1.04e-03 | 16 | 62 | 2 | GO:1904181 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.09e-03 | 389 | 62 | 6 | GO:0055074 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 P2RY1 TRPV4 HMGCR VPS54 ATP1A1 ATP1A4 | 1.12e-03 | 1249 | 62 | 11 | GO:0048878 |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.17e-03 | 17 | 62 | 2 | GO:0030007 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle contraction | 1.17e-03 | 17 | 62 | 2 | GO:0045989 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.17e-03 | 17 | 62 | 2 | GO:0036376 | |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1C CACNA1D TPCN2 NPY5R P2RY1 MRGPRX1 MRGPRX3 TRPV4 MRGPRX4 HMGCR | 1.19e-03 | 1064 | 62 | 10 | GO:0032940 |
| GeneOntologyBiologicalProcess | muscle system process | 1.24e-03 | 547 | 62 | 7 | GO:0003012 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.26e-03 | 400 | 62 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.41e-03 | 275 | 62 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | mast cell degranulation | 1.44e-03 | 74 | 62 | 3 | GO:0043303 | |
| GeneOntologyBiologicalProcess | mast cell mediated immunity | 1.56e-03 | 76 | 62 | 3 | GO:0002448 | |
| GeneOntologyBiologicalProcess | mast cell activation involved in immune response | 1.68e-03 | 78 | 62 | 3 | GO:0002279 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 1.81e-03 | 291 | 62 | 5 | GO:0045055 | |
| GeneOntologyBiologicalProcess | exocytosis | 1.91e-03 | 434 | 62 | 6 | GO:0006887 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.98e-03 | 22 | 62 | 2 | GO:1902514 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 2.16e-03 | 23 | 62 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 2.16e-03 | 23 | 62 | 2 | GO:0061577 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.29e-03 | 87 | 62 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1C CACNA1D CACNA1F SLC9C1 TPCN2 P2RY1 SLC5A7 TRPV4 ATP1A1 TMC5 ATP1A4 | 2.41e-03 | 1374 | 62 | 11 | GO:0006811 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 3.54e-04 | 43 | 67 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.33e-04 | 46 | 67 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | cell body membrane | 4.61e-04 | 47 | 67 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 6.54e-04 | 12 | 67 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 6.54e-04 | 12 | 67 | 2 | GO:0005890 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.67e-03 | 73 | 67 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 2.09e-03 | 79 | 67 | 3 | GO:0030315 | |
| HumanPheno | Areflexia | 8.90e-06 | 314 | 10 | 6 | HP:0001284 | |
| HumanPheno | Proximal muscle weakness | 1.41e-05 | 340 | 10 | 6 | HP:0003701 | |
| HumanPheno | Limb muscle weakness | 1.94e-05 | 359 | 10 | 6 | HP:0003690 | |
| HumanPheno | Hyporeflexia | 4.34e-05 | 413 | 10 | 6 | HP:0001265 | |
| HumanPheno | Stridor | 1.02e-04 | 50 | 10 | 3 | HP:0010307 | |
| HumanPheno | Abnormality of peripheral nerve conduction | 1.29e-04 | 149 | 10 | 4 | HP:0003134 | |
| HumanPheno | Abnormal peripheral nerve morphology by anatomical site | 1.46e-04 | 154 | 10 | 4 | HP:0045010 | |
| HumanPheno | Abnormal motor nerve conduction velocity | 2.55e-04 | 68 | 10 | 3 | HP:0040131 | |
| HumanPheno | Skeletal muscle atrophy | 2.95e-04 | 579 | 10 | 6 | HP:0003202 | |
| HumanPheno | Proximal muscle weakness in lower limbs | 3.04e-04 | 186 | 10 | 4 | HP:0008994 | |
| HumanPheno | Obstructive sleep apnea | 3.98e-04 | 79 | 10 | 3 | HP:0002870 | |
| HumanPheno | Hypokalemia | 3.98e-04 | 79 | 10 | 3 | HP:0002900 | |
| HumanPheno | Reduced tendon reflexes | 4.21e-04 | 617 | 10 | 6 | HP:0001315 | |
| HumanPheno | Upper limb amyotrophy | 4.61e-04 | 83 | 10 | 3 | HP:0009129 | |
| HumanPheno | Diaphragmatic weakness | 4.64e-04 | 17 | 10 | 2 | HP:0009113 | |
| HumanPheno | Abnormality of the musculature of the limbs | 6.01e-04 | 658 | 10 | 6 | HP:0009127 | |
| HumanPheno | Distal amyotrophy | 6.86e-04 | 230 | 10 | 4 | HP:0003693 | |
| HumanPheno | Distal lower limb muscle weakness | 7.07e-04 | 96 | 10 | 3 | HP:0009053 | |
| HumanPheno | Facial palsy | 7.09e-04 | 232 | 10 | 4 | HP:0010628 | |
| HumanPheno | Abnormal seventh cranial physiology | 7.20e-04 | 233 | 10 | 4 | HP:0010827 | |
| HumanPheno | Decreased fetal movement | 7.32e-04 | 234 | 10 | 4 | HP:0001558 | |
| HumanPheno | Juvenile onset | 8.46e-04 | 700 | 10 | 6 | HP:0003621 | |
| HumanPheno | Respiratory insufficiency due to muscle weakness | 8.69e-04 | 103 | 10 | 3 | HP:0002747 | |
| HumanPheno | Prenatal movement abnormality | 8.85e-04 | 246 | 10 | 4 | HP:0001557 | |
| HumanPheno | Abnormality of skeletal muscles | 1.04e-03 | 727 | 10 | 6 | HP:0040290 | |
| HumanPheno | Amyotrophy involving the extremities | 1.11e-03 | 112 | 10 | 3 | HP:0003671 | |
| HumanPheno | Abnormal blood potassium concentration | 1.14e-03 | 113 | 10 | 3 | HP:0011042 | |
| HumanPheno | Abnormality of muscle size | 1.15e-03 | 740 | 10 | 6 | HP:0030236 | |
| HumanPheno | Weakness of muscles of respiration | 1.23e-03 | 116 | 10 | 3 | HP:0004347 | |
| HumanPheno | Weakness of facial musculature | 1.24e-03 | 269 | 10 | 4 | HP:0030319 | |
| HumanPheno | Abnormal nerve conduction velocity | 1.32e-03 | 119 | 10 | 3 | HP:0040129 | |
| HumanPheno | Abnormal motor neuron morphology | 1.49e-03 | 501 | 10 | 5 | HP:0002450 | |
| HumanPheno | Central sleep apnea | 1.56e-03 | 31 | 10 | 2 | HP:0010536 | |
| HumanPheno | Abnormal neuron morphology | 1.58e-03 | 507 | 10 | 5 | HP:0012757 | |
| HumanPheno | Increased endomysial connective tissue | 1.67e-03 | 32 | 10 | 2 | HP:0100297 | |
| HumanPheno | Abnormality of the musculature of the lower limbs | 1.80e-03 | 297 | 10 | 4 | HP:0001437 | |
| HumanPheno | Abnormal breath sound | 1.83e-03 | 133 | 10 | 3 | HP:0030829 | |
| HumanPheno | Abnormal muscle fiber morphology | 1.91e-03 | 302 | 10 | 4 | HP:0004303 | |
| HumanPheno | Pes cavus | 1.96e-03 | 304 | 10 | 4 | HP:0001761 | |
| HumanPheno | Elevated circulating creatine kinase concentration | 2.01e-03 | 306 | 10 | 4 | HP:0003236 | |
| HumanPheno | Abnormal fetal physiology | 2.06e-03 | 308 | 10 | 4 | HP:0034059 | |
| HumanPheno | EMG: impaired neuromuscular transmission | 2.11e-03 | 36 | 10 | 2 | HP:0100285 | |
| HumanPheno | Abnormality of peripheral nervous system electrophysiology | 2.24e-03 | 315 | 10 | 4 | HP:0030177 | |
| HumanPheno | Foot dorsiflexor weakness | 2.29e-03 | 144 | 10 | 3 | HP:0009027 | |
| HumanPheno | Abnormal peripheral nervous system physiology | 2.34e-03 | 319 | 10 | 4 | HP:0032120 | |
| HumanPheno | Motor polyneuropathy | 2.35e-03 | 38 | 10 | 2 | HP:0007178 | |
| HumanPheno | Abnormal circulating creatine kinase concentration | 2.43e-03 | 322 | 10 | 4 | HP:0040081 | |
| HumanPheno | Abnormal circulating enzyme concentration | 2.60e-03 | 328 | 10 | 4 | HP:0011021 | |
| HumanPheno | Dysphagia | 2.62e-03 | 567 | 10 | 5 | HP:0002015 | |
| HumanPheno | Cranial nerve paralysis | 2.63e-03 | 329 | 10 | 4 | HP:0006824 | |
| HumanPheno | Upper limb muscle weakness | 2.63e-03 | 151 | 10 | 3 | HP:0003484 | |
| HumanPheno | Abnormality of the foot musculature | 2.63e-03 | 151 | 10 | 3 | HP:0001436 | |
| HumanPheno | Abnormal cranial nerve physiology | 2.72e-03 | 332 | 10 | 4 | HP:0031910 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 2.78e-03 | 154 | 10 | 3 | HP:0010930 | |
| HumanPheno | Fetal anomaly | 2.79e-03 | 575 | 10 | 5 | HP:0034057 | |
| HumanPheno | Paralysis | 3.05e-03 | 159 | 10 | 3 | HP:0003470 | |
| HumanPheno | Slowly progressive | 3.16e-03 | 161 | 10 | 3 | HP:0003677 | |
| MousePheno | decreased pruritus | 2.51e-07 | 7 | 28 | 3 | MP:0010073 | |
| MousePheno | abnormal pruritus | 1.56e-06 | 12 | 28 | 3 | MP:0010071 | |
| MousePheno | abnormal neuron physiology | 1.67e-05 | 604 | 28 | 8 | MP:0004811 | |
| MousePheno | abnormal skin physiology | 1.87e-05 | 288 | 28 | 6 | MP:0005501 | |
| Domain | 7tm_1 | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 MRGPRX3 OR10H4 MRGPRX4 OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 | 2.17e-32 | 677 | 59 | 33 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 MRGPRX3 OR10H4 MRGPRX4 OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 | 3.19e-32 | 685 | 59 | 33 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 MRGPRX3 OR10H4 MRGPRX4 OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 | 4.25e-32 | 691 | 59 | 33 | PS50262 |
| Domain | GPCR_Rhodpsn | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 MRGPRX3 OR10H4 MRGPRX4 OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 | 4.46e-32 | 692 | 59 | 33 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 NPY5R P2RY1 OR13C5 MRGPRX1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 MRGPRX3 OR10H4 MRGPRX4 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 CXCR1 OR4F6 | 5.33e-31 | 670 | 59 | 32 | IPR017452 |
| Domain | Olfact_rcpt | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 OR10H4 OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 | 5.67e-30 | 393 | 59 | 27 | IPR000725 |
| Domain | CAC1F_C | 2.99e-08 | 3 | 59 | 3 | PF16885 | |
| Domain | CAC1F_C | 2.99e-08 | 3 | 59 | 3 | IPR031688 | |
| Domain | VDCC_L_a1su | 1.20e-07 | 4 | 59 | 3 | IPR005446 | |
| Domain | GPHH_dom | 1.04e-06 | 7 | 59 | 3 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 1.04e-06 | 7 | 59 | 3 | IPR014873 | |
| Domain | Ca_chan_IQ | 1.04e-06 | 7 | 59 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.04e-06 | 7 | 59 | 3 | PF08763 | |
| Domain | GPHH | 1.04e-06 | 7 | 59 | 3 | PF16905 | |
| Domain | Ion_trans_dom | 1.57e-06 | 114 | 59 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.57e-06 | 114 | 59 | 6 | PF00520 | |
| Domain | VDCCAlpha1 | 3.54e-06 | 10 | 59 | 3 | IPR002077 | |
| Domain | MRGPCRFAMILY | 4.85e-06 | 11 | 59 | 3 | IPR026234 | |
| Domain | Channel_four-helix_dom | 3.13e-05 | 57 | 59 | 4 | IPR027359 | |
| Domain | - | 3.13e-05 | 57 | 59 | 4 | 1.20.120.350 | |
| Domain | P-type_ATPase_IIC | 1.46e-04 | 6 | 59 | 2 | IPR005775 | |
| Domain | - | 1.14e-03 | 16 | 59 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 1.14e-03 | 16 | 59 | 2 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.29e-03 | 17 | 59 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.29e-03 | 17 | 59 | 2 | PF00689 | |
| Domain | Cation_ATPase_N | 1.45e-03 | 18 | 59 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 1.45e-03 | 18 | 59 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.62e-03 | 19 | 59 | 2 | IPR004014 | |
| Domain | TM4_1 | 3.04e-03 | 26 | 59 | 2 | PS00421 | |
| Domain | Tetraspanin | 4.58e-03 | 32 | 59 | 2 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 4.58e-03 | 32 | 59 | 2 | IPR008952 | |
| Domain | - | 4.58e-03 | 32 | 59 | 2 | 2.70.150.10 | |
| Domain | - | 4.58e-03 | 32 | 59 | 2 | 3.40.1110.10 | |
| Domain | Tetraspannin | 4.86e-03 | 33 | 59 | 2 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 4.86e-03 | 33 | 59 | 2 | IPR018499 | |
| Domain | ATPase_P-typ_cyto_domN | 5.46e-03 | 35 | 59 | 2 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 5.77e-03 | 36 | 59 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 5.77e-03 | 36 | 59 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 5.77e-03 | 36 | 59 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.09e-03 | 37 | 59 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.09e-03 | 37 | 59 | 2 | PF00122 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 | 6.17e-30 | 417 | 56 | 29 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR10A6 OR2D2 OR10H4 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 | 3.94e-26 | 389 | 56 | 26 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR10A3 OR2W3 OR51T1 CACNA1D OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR2J1 OR6K3 OR4C12 OR10J4 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 | 4.82e-26 | 636 | 56 | 30 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.05e-08 | 70 | 56 | 7 | MM14984 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.18e-06 | 6 | 56 | 3 | M47762 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 9.60e-06 | 190 | 56 | 7 | MM15687 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.49e-05 | 79 | 56 | 5 | M17673 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.10e-05 | 14 | 56 | 3 | M47692 | |
| Pathway | WP_GPCRS_ODORANT | 3.56e-05 | 157 | 56 | 6 | MM15872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 9.94e-05 | 23 | 56 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.28e-04 | 25 | 56 | 3 | M47948 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.57e-04 | 260 | 56 | 6 | M39397 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 7.80e-04 | 183 | 56 | 5 | M997 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.15e-03 | 74 | 56 | 3 | M39462 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.15e-03 | 74 | 56 | 3 | MM15962 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.15e-03 | 74 | 56 | 3 | M16376 | |
| Pubmed | OR10A3 OR2W3 OR51T1 OR5T1 OR13D1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR6K6 OR4L1 OR4F6 OR2W6P | 7.01e-37 | 343 | 67 | 27 | 32295537 | |
| Pubmed | OR10A3 OR2W3 OR51T1 OR5T1 OR13D1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR6K6 OR4L1 OR4F6 OR2W6P | 8.92e-37 | 346 | 67 | 27 | 14611657 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR10A3 OR2W3 OR51T1 OR5T1 OR13D1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR4L1 OR4F6 OR2W6P | 3.97e-35 | 340 | 67 | 26 | 11875048 |
| Pubmed | OR10A3 OR2W3 OR51T1 OR5T1 OR13D1 OR4A47 OR9Q2 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR5AK3P OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR4L1 OR4F6 OR2W6P | 3.97e-35 | 340 | 67 | 26 | 11802173 | |
| Pubmed | OR10A3 OR2W3 OR51T1 OR5T1 OR4S1 OR13D1 OR13C5 OR4A47 OR52E8 OR10K1 OR2D3 OR1P1 OR10A6 OR2D2 OR10H4 OR2J1 OR6K3 OR4C12 OR56A4 OR5M3 OR5M11 OR52K2 OR2B6 OR1L3 OR6K6 OR4L1 OR4F6 OR2W6P | 3.92e-33 | 541 | 67 | 28 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR10A3 OR2W3 OR4A47 OR2D3 OR1P1 OR2D2 OR10H4 OR4C12 OR10J4 OR5M3 OR5M11 | 4.52e-13 | 219 | 67 | 11 | 12213199 |
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 10662793 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 28768771 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 26022362 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 27215903 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 18250432 | ||
| Pubmed | 6.83e-09 | 3 | 67 | 3 | 31119828 | ||
| Pubmed | Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs. | 6.83e-09 | 3 | 67 | 3 | 11850634 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 11821156 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 17975009 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 23074220 | ||
| Pubmed | Characterization of new G protein-coupled adenine receptors in mouse and hamster. | 2.73e-08 | 4 | 67 | 3 | 23608776 | |
| Pubmed | The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. | 2.73e-08 | 4 | 67 | 3 | 21775281 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 26874069 | ||
| Pubmed | Tick peptides evoke itch by activating MrgprC11/MRGPRX1 to sensitize TRPV1 in pruriceptors. | 2.73e-08 | 4 | 67 | 3 | 33358893 | |
| Pubmed | MrgprA3 shows sensitization to chloroquine in an acetone-ether-water mice model. | 2.73e-08 | 4 | 67 | 3 | 29064954 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 36864656 | ||
| Pubmed | Low maternal care enhances the skin barrier resistance of offspring in mice. | 2.73e-08 | 4 | 67 | 3 | 31295326 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 20937870 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 33727332 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 10504302 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 28545921 | ||
| Pubmed | Substance P activates Mas-related G protein-coupled receptors to induce itch. | 2.73e-08 | 4 | 67 | 3 | 28219706 | |
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 35882236 | ||
| Pubmed | 2.73e-08 | 4 | 67 | 3 | 32234460 | ||
| Pubmed | Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. | 6.81e-08 | 5 | 67 | 3 | 20004959 | |
| Pubmed | Hippocampal short- and long-term plasticity are not modulated by astrocyte Ca2+ signaling. | 6.81e-08 | 5 | 67 | 3 | 20203048 | |
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 17618277 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 10698974 | ||
| Pubmed | 6.81e-08 | 5 | 67 | 3 | 38735364 | ||
| Pubmed | MrgprB4 in trigeminal neurons expressing TRPA1 modulates unpleasant sensations. | 6.81e-08 | 5 | 67 | 3 | 34116733 | |
| Pubmed | Astrocytes modulate neural network activity by Ca²+-dependent uptake of extracellular K+. | 6.81e-08 | 5 | 67 | 3 | 22472648 | |
| Pubmed | Cross-sensitization of histamine-independent itch in mouse primary sensory neurons. | 6.81e-08 | 5 | 67 | 3 | 23000623 | |
| Pubmed | Genetic identification of C fibres that detect massage-like stroking of hairy skin in vivo. | 1.36e-07 | 6 | 67 | 3 | 23364746 | |
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 23263443 | ||
| Pubmed | Identification of a bilirubin receptor that may mediate a component of cholestatic itch. | 1.36e-07 | 6 | 67 | 3 | 30657454 | |
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 24549959 | ||
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 33091423 | ||
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 26216096 | ||
| Pubmed | 1.36e-07 | 6 | 67 | 3 | 33876765 | ||
| Pubmed | Touch neurons underlying dopaminergic pleasurable touch and sexual receptivity. | 2.38e-07 | 7 | 67 | 3 | 36693373 | |
| Pubmed | 2.38e-07 | 7 | 67 | 3 | 12900400 | ||
| Pubmed | Comparative genomic analysis of eutherian Mas-related G protein-coupled receptor genes. | 3.80e-07 | 8 | 67 | 3 | 24583173 | |
| Pubmed | Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. | 3.80e-07 | 8 | 67 | 3 | 12909716 | |
| Pubmed | 5.69e-07 | 9 | 67 | 3 | 12397184 | ||
| Pubmed | 5.69e-07 | 9 | 67 | 3 | 30886406 | ||
| Pubmed | 8.12e-07 | 10 | 67 | 3 | 33098765 | ||
| Pubmed | A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. | 1.12e-06 | 11 | 67 | 3 | 11551509 | |
| Pubmed | 1.12e-06 | 11 | 67 | 3 | 18809727 | ||
| Pubmed | 1.12e-06 | 11 | 67 | 3 | 21151121 | ||
| Pubmed | Parallel ascending spinal pathways for affective touch and pain. | 2.45e-06 | 14 | 67 | 3 | 33116307 | |
| Pubmed | A brain-to-spinal sensorimotor loop for repetitive self-grooming. | 3.06e-06 | 15 | 67 | 3 | 34932943 | |
| Pubmed | 3.06e-06 | 15 | 67 | 3 | 20188150 | ||
| Pubmed | DRG afferents that mediate physiologic and pathologic mechanosensation from the distal colon. | 3.06e-06 | 15 | 67 | 3 | 37541195 | |
| Pubmed | 3.06e-06 | 15 | 67 | 3 | 24453333 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 26475857 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24849370 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 20014384 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 3.66e-06 | 2 | 67 | 2 | 26049024 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 17015854 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 30001160 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 3.66e-06 | 2 | 67 | 2 | 16706838 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 23761887 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 14981074 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 21352396 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 3.66e-06 | 2 | 67 | 2 | 25292336 | |
| Pubmed | Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. | 3.66e-06 | 2 | 67 | 2 | 23913004 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 17526649 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 3.66e-06 | 2 | 67 | 2 | 24941892 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 3.66e-06 | 2 | 67 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 3.66e-06 | 2 | 67 | 2 | 16267232 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24848473 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 3.66e-06 | 2 | 67 | 2 | 16921373 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24996399 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24470632 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 3.66e-06 | 2 | 67 | 2 | 25966695 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24760982 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 24086669 | ||
| Pubmed | 4.56e-06 | 17 | 67 | 3 | 25834056 | ||
| Pubmed | 5.46e-06 | 18 | 67 | 3 | 29045838 | ||
| Pubmed | C-LTMRs mediate wet dog shakes via the spinoparabrachial pathway. | 6.48e-06 | 19 | 67 | 3 | 38915692 | |
| Pubmed | 6.48e-06 | 19 | 67 | 3 | 22787056 | ||
| Pubmed | 6.48e-06 | 19 | 67 | 3 | 24516396 | ||
| Pubmed | Meis1 Regulates Nociceptor Development and Behavioral Response to Tactile Stimuli. | 7.61e-06 | 20 | 67 | 3 | 35875660 | |
| Pubmed | Hierarchical Specification of Pruriceptors by Runt-Domain Transcription Factor Runx1. | 8.87e-06 | 21 | 67 | 3 | 28476948 | |
| Pubmed | 8.87e-06 | 21 | 67 | 3 | 25369838 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19351867 | ||
| Pubmed | Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. | 1.10e-05 | 3 | 67 | 2 | 26285814 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 28584016 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 1.10e-05 | 3 | 67 | 2 | 21832054 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 17289261 | ||
| Interaction | CACNA1D interactions | 2.32e-05 | 24 | 47 | 3 | int:CACNA1D | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | OR10A3 OR51T1 MRGPRX1 OR52E8 OR2D3 OR10A6 OR2D2 MRGPRX3 MRGPRX4 CD151 OR56A4 OR52K2 | 3.42e-11 | 564 | 67 | 12 | chr11p15 |
| Cytoband | 11p15.4 | 5.90e-10 | 200 | 67 | 8 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 1.03e-06 | 226 | 67 | 6 | chr1q23 | |
| Cytoband | 11q12.1 | 4.04e-06 | 161 | 67 | 5 | 11q12.1 | |
| Cytoband | 1q23.1 | 4.31e-05 | 46 | 67 | 3 | 1q23.1 | |
| Cytoband | 11p15.1 | 9.58e-05 | 60 | 67 | 3 | 11p15.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.53e-04 | 345 | 67 | 5 | chr11q12 | |
| Cytoband | 7q11.23 | 3.97e-04 | 97 | 67 | 3 | 7q11.23 | |
| Cytoband | 1q23.2 | 1.21e-03 | 35 | 67 | 2 | 1q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p11 | 1.49e-03 | 153 | 67 | 3 | chr11p11 | |
| Cytoband | 9q31.1 | 1.66e-03 | 41 | 67 | 2 | 9q31.1 | |
| Cytoband | 11p11.2 | 6.62e-03 | 83 | 67 | 2 | 11p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 7.38e-03 | 271 | 67 | 3 | chr7q11 | |
| GeneFamily | Olfactory receptors, family 2 | 1.98e-06 | 113 | 60 | 6 | 149 | |
| GeneFamily | Olfactory receptors, family 10 | 2.60e-06 | 66 | 60 | 5 | 157 | |
| GeneFamily | Olfactory receptors, family 4 | 6.82e-05 | 129 | 60 | 5 | 151 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.56e-05 | 26 | 60 | 3 | 253 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 2.25e-04 | 7 | 60 | 2 | 1208 | |
| GeneFamily | Olfactory receptors, family 5 | 5.21e-04 | 112 | 60 | 4 | 152 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.21e-03 | 78 | 60 | 3 | 262 | |
| GeneFamily | Olfactory receptors, family 13 | 2.62e-03 | 23 | 60 | 2 | 162 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.60e-03 | 27 | 60 | 2 | 1253 | |
| GeneFamily | CD molecules|Tetraspanins | 5.35e-03 | 33 | 60 | 2 | 768 | |
| GeneFamily | Olfactory receptors, family 1 | 7.79e-03 | 40 | 60 | 2 | 147 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 8.56e-03 | 42 | 60 | 2 | 602 | |
| GeneFamily | Olfactory receptors, family 52 | 1.15e-02 | 49 | 60 | 2 | 165 | |
| GeneFamily | Olfactory receptors, family 6 | 1.24e-02 | 51 | 60 | 2 | 153 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 162 | 64 | 5 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 162 | 64 | 5 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 162 | 64 | 5 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 162 | 64 | 5 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.18e-06 | 174 | 64 | 5 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.63e-06 | 177 | 64 | 5 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 185 | 64 | 5 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 185 | 64 | 5 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 185 | 64 | 5 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-06 | 188 | 64 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-06 | 189 | 64 | 5 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 190 | 64 | 5 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 194 | 64 | 5 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 194 | 64 | 5 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.81e-05 | 146 | 64 | 4 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 154 | 64 | 4 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 154 | 64 | 4 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 154 | 64 | 4 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 154 | 64 | 4 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 9.34e-05 | 165 | 64 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 170 | 64 | 4 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 174 | 64 | 4 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 177 | 64 | 4 | 8c78f7de091f16e86e326a73c9f1429e0232821f | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-04 | 178 | 64 | 4 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-04 | 178 | 64 | 4 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 180 | 64 | 4 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 180 | 64 | 4 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 181 | 64 | 4 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 181 | 64 | 4 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 181 | 64 | 4 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | wk_15-18-Epithelial-PNS-Late_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 182 | 64 | 4 | 6462e0469224457e249d10e224082f727caa02d6 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.39e-04 | 183 | 64 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 184 | 64 | 4 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | wk_08-11-Epithelial-PNS-COL20A1+_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 185 | 64 | 4 | abec2a49fe0f0fa4cba49347207a1ee317333657 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 186 | 64 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 186 | 64 | 4 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 188 | 64 | 4 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 189 | 64 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | wk_08-11-Epithelial-PNS-Early_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 190 | 64 | 4 | 8190674a48607984726974765aafbca116f437e0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | 15-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 1.77e-04 | 195 | 64 | 4 | 56356a9aeb67b50a74425be2cd9c50d31416c1b3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | 359b9d791e26844675c3c60cf69d8ab69c2cf400 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 196 | 64 | 4 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-04 | 198 | 64 | 4 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 199 | 64 | 4 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-04 | 200 | 64 | 4 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| Drug | Cinnarizine | 1.68e-06 | 9 | 63 | 3 | DB00568 | |
| Drug | Nimodipine | 1.68e-06 | 9 | 63 | 3 | DB00393 | |
| Drug | Mibefradil | 3.28e-06 | 11 | 63 | 3 | DB01388 | |
| Drug | manidipine | 6.60e-06 | 95 | 63 | 5 | CID000004008 | |
| Drug | Verapamil | 1.10e-05 | 16 | 63 | 3 | DB00661 | |
| Drug | Cinildipine | 1.75e-05 | 56 | 63 | 4 | CID000002752 | |
| Drug | nilvadipine | 2.31e-05 | 60 | 63 | 4 | CID000004494 | |
| Drug | bepridil | 2.61e-05 | 126 | 63 | 5 | CID000002351 | |
| Drug | lercanidipine | 2.80e-05 | 63 | 63 | 4 | CID000065866 | |
| Drug | gallopamil | 3.58e-05 | 67 | 63 | 4 | CID000001234 | |
| Drug | AC1L2AC7 | 4.02e-05 | 69 | 63 | 4 | CID000068733 | |
| Drug | NSC-686960 | 4.51e-05 | 4 | 63 | 2 | CID000192816 | |
| Drug | CAS 298-57-7 | 5.02e-05 | 73 | 63 | 4 | CID000002761 | |
| Drug | ethosuximide | 5.30e-05 | 74 | 63 | 4 | CID000003291 | |
| Drug | nisoldipine | 6.51e-05 | 78 | 63 | 4 | CID000004499 | |
| Drug | methyl beta-aminocrotonate | 7.50e-05 | 5 | 63 | 2 | CID000084253 | |
| Drug | Nilvadipine | 7.50e-05 | 5 | 63 | 2 | DB06712 | |
| Drug | Nisoldipine | 7.50e-05 | 5 | 63 | 2 | DB00401 | |
| Drug | nemadipine-A | 7.50e-05 | 5 | 63 | 2 | CID002856102 | |
| Drug | B 874-67 | 7.50e-05 | 5 | 63 | 2 | CID000195466 | |
| Drug | CNS 1145 | 1.04e-04 | 33 | 63 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.04e-04 | 33 | 63 | 3 | CID000162753 | |
| Drug | CPU-23 | 1.12e-04 | 6 | 63 | 2 | CID003036051 | |
| Drug | oleandrin | 1.12e-04 | 6 | 63 | 2 | ctd:C021065 | |
| Drug | isotetrandrine | 1.52e-04 | 97 | 63 | 4 | CID000005422 | |
| Drug | Amlodipine | 1.57e-04 | 7 | 63 | 2 | DB00381 | |
| Drug | Isradipine | 1.57e-04 | 7 | 63 | 2 | DB00270 | |
| Drug | nitrendipine | 1.58e-04 | 98 | 63 | 4 | CID000004507 | |
| Drug | isradipine | 1.71e-04 | 100 | 63 | 4 | CID000003784 | |
| Drug | loperamide | 2.06e-04 | 105 | 63 | 4 | CID000003954 | |
| Drug | Nitrendipine | 2.09e-04 | 8 | 63 | 2 | DB01054 | |
| Drug | 1,5-benzothiazepin-4(5H)-one | 2.09e-04 | 8 | 63 | 2 | CID000358939 | |
| Drug | Nifedipine | 2.09e-04 | 8 | 63 | 2 | DB01115 | |
| Drug | Sterols | 2.68e-04 | 9 | 63 | 2 | ctd:D013261 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.19e-08 | 4 | 60 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.44e-05 | 36 | 60 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Conn Syndrome | 6.07e-05 | 6 | 60 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 6.07e-05 | 6 | 60 | 2 | C0020428 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 8.48e-05 | 7 | 60 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Hereditary Motor and Sensory Neuropathy Type I | 1.13e-04 | 8 | 60 | 2 | C0751036 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ib | 1.13e-04 | 8 | 60 | 2 | C0270912 | |
| Disease | Charcot-Marie-Tooth Disease, Type Ia (disorder) | 1.13e-04 | 8 | 60 | 2 | C0270911 | |
| Disease | Roussy-Levy Syndrome (disorder) | 1.13e-04 | 8 | 60 | 2 | C0205713 | |
| Disease | Charcot-Marie-Tooth Disease | 2.65e-04 | 12 | 60 | 2 | C0007959 | |
| Disease | nervous system disease (implicated_via_orthology) | 2.65e-04 | 12 | 60 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 3.13e-04 | 13 | 60 | 2 | C0270914 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 5.42e-04 | 17 | 60 | 2 | cv:C0270914 | |
| Disease | response to tenofovir, creatinine clearance measurement | 1.56e-03 | 112 | 60 | 3 | EFO_0007934, EFO_0009279 | |
| Disease | Myopathy | 1.71e-03 | 30 | 60 | 2 | C0026848 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIVISYSFILKVVLR | 216 | Q8NGH8 | |
| VLLLALVIFYLTLII | 146 | Q01151 | |
| VLVVLFLLALFIIYR | 866 | Q96KG7 | |
| ALLVLFVIIIYAIIG | 241 | O60840 | |
| ILVILVSYLFIIVAI | 211 | Q8NGE9 | |
| LLFVLFLVVYLVTLL | 26 | Q96RB7 | |
| FLIIALSYVRIVTVI | 226 | Q8NGY3 | |
| RKSIYLVIIVLTVFA | 256 | P47900 | |
| FLLILLSYIRVLFAI | 211 | P58181 | |
| LTLILISYAFIVRAV | 211 | P58173 | |
| VVLFVVILIFYLITL | 26 | Q9GZK6 | |
| LLNFLILVVSYVIIL | 206 | Q96R67 | |
| DIIILTITRCIAILY | 61 | P04035 | |
| LLIFVYDEVRKLIIR | 996 | P05023 | |
| TIVFLLLLISYGVIL | 206 | Q6IF82 | |
| ILFVVILIAYLLTLV | 26 | Q7Z3T1 | |
| LIVFVVVLIFYLLTL | 31 | Q8NHA6 | |
| ILFSYVLILRTVLGI | 216 | Q8NGJ9 | |
| FLILIISYIFILVTV | 211 | Q8NGB9 | |
| FILLLVSYIVILVSV | 211 | Q8NH43 | |
| ILIISYVIILLNLRS | 211 | Q8NGB4 | |
| LTRLYVTILLTVLVF | 211 | Q96LB0 | |
| ILLFILFLIIYLLTV | 41 | Q8NGH3 | |
| LLLIIVSYTLIILSI | 211 | Q8NGS8 | |
| VIIISYLFILIAILR | 211 | Q8NGP4 | |
| VLFIVLLLIYVTSLI | 26 | Q8NH89 | |
| IILSYVFIVAAILRI | 216 | Q8NGA5 | |
| LLFIVLLGVYLVTVL | 26 | Q9H210 | |
| VESVLLGIVILLAYR | 21 | Q96GM1 | |
| VTILIVLISYGFILL | 221 | Q8NG75 | |
| IALLVLFVIIIYAII | 271 | Q13936 | |
| VVIIAYALVFLLSLL | 41 | P25024 | |
| ILLAIVVLYVALRRQ | 626 | P55289 | |
| RLYFILLLIIFLLEI | 91 | P48509 | |
| RILYLFLALLLVAVA | 56 | Q6AZY7 | |
| LLHIALLVLFVIIIY | 271 | Q01668 | |
| LLVLFVIIIYAIIGL | 276 | Q01668 | |
| FLLILLSYIRVLFAI | 211 | Q8NH74 | |
| ASFLVIALSYIRIII | 236 | Q8NGW6 | |
| FVCIIISYLRILIAV | 211 | Q8NH93 | |
| LILFVIFLVLYVLTL | 26 | P0C629 | |
| LLLILVSYIRIISAI | 211 | Q8NGX5 | |
| LILVSYIRIVSAILR | 226 | Q8NH06 | |
| IVSLVILLLLIFISY | 236 | Q8NGV5 | |
| LLLLDVILIILSYVR | 211 | Q6IFG1 | |
| VILSYIFILQAVLLL | 216 | Q8NGK3 | |
| LIILIIFLVLFIYTL | 1831 | Q2WGJ9 | |
| EGLIAIIVFYLLILL | 6 | Q9GZV3 | |
| LNIYLTLIVLRFLTL | 331 | Q4G0N8 | |
| ALFLSVLVILLVIYV | 426 | Q86VH5 | |
| LGAIFLLLVLLVVIY | 361 | Q9NP60 | |
| LVSTLILISIAIVRY | 126 | Q15761 | |
| ILVASYVILLLVFLI | 16 | A0A1B0GVT2 | |
| YSVAVEAVRLLILIL | 101 | P0CL83 | |
| LTRLYVTILLTVLVF | 211 | Q96LB2 | |
| LTRLYVTILLTVLVF | 211 | Q96LA9 | |
| SILIFVYDEIRKLLI | 1001 | Q13733 | |
| FVVLVISIAILYLRF | 501 | Q9P2C4 | |
| FLGVLLTLLYITRVE | 246 | O95858 | |
| YSVAVEAVRLLILIL | 101 | P0CL84 | |
| FIALALVEVYRDIIL | 1091 | Q2NKQ1 | |
| LVIIERLLLLAERYV | 921 | Q9UPU5 | |
| YSVAVEAVRLLILIL | 101 | P0CL85 | |
| VYVLLIRNIFLKISI | 691 | Q6UXY8 | |
| IILLVTYIILTFVLL | 696 | Q9HBA0 | |
| VLLVLEISTLAVYRL | 511 | Q8NHX9 | |
| VVGTVLLLIRIILEY | 741 | Q9P1Q0 | |
| LGVVLLLLLLFYVVR | 166 | P25189 |